Stockreport

Marinus Pharmaceuticals' Oral Seizure Drug Disappoints In Late-Stage Study, Appoints Advisor To Explore Options [Yahoo! Finance]

Marinus Pharmaceuticals, Inc.  (MRNS) 
Last marinus pharmaceuticals, inc. earnings: 11/6 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.marinuspharma.com/investor-relations
PDF trial of oral ganaxolone for seizures associated with tuberous sclerosis complex (TSC) in children and adults TSC is a rare genetic condition that mainly causes non-ca [Read more]